CD40LG and myeloid sarcoma: Notably, changes in the composition of CSF of MS patients (e.g. cytokine, chemokine, IgG and IgM levels) have been used as key disease biomarkers, assisting in the diagnosis of MS and allowing for the stratification of MS patients and improved understanding of pathophysiological mechanisms.